These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Comments to "a rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M Gene; 2014 Jan; 534(2):451-2. PubMed ID: 24100083 [No Abstract] [Full Text] [Related]
13. E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Kirby-Keyser L; Porter CC; Donohoue PA Hum Mutat; 1997; 9(2):181-2. PubMed ID: 9067760 [No Abstract] [Full Text] [Related]
14. Comments to “A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency”. Concolino P; Mello E; Rossodivita A; Giardina B; Capoluongo E Gene; 2014 Jan; 534(2):449-450. PubMed ID: 24501745 [No Abstract] [Full Text] [Related]
15. Study of a kindred with classic congenital adrenal hyperplasia: diagnostic challenge due to phenotypic variance. Chin D; Speiser PW; Imperato-McGinley J; Dixit N; Uli N; David R; Oberfield SE J Clin Endocrinol Metab; 1998 Jun; 83(6):1940-5. PubMed ID: 9626123 [TBL] [Abstract][Full Text] [Related]